Researchers reveal the cellular makeup of each glioblastoma brain tumor is more heterogeneous than previously believed.
Researchers identify two adult cancer medications which have the potential to improve treatment for medulloblastoma brain cancer in children.
Researchers have developed a unique and inexpensive device which lights up malignant brain tumors.
Researchers identify the most common genetic alteration in ependymoma brain tumors.
Researchers discover an enzyme, IDH, which facilitates the breakdown of specific amino acids makes glioblastoma brain cancer particularly aggressive.